Research output per year
Research output per year
Personal profile
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Fingerprint
Dive into the research topics where Coba van Zanten is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Development of an Adaptable Qualification Test Set for Personnel Involved in Visual Inspection Procedures of Parenteral Drug Products Manufactured Under Good Manufacturing Practice Conditions in Hospital Pharmacy Compounding Facilities
van den Born-Bondt, T., Huizinga, H. P. S., Kappert, K. R., Westra, H. H., van Zanten, J., Woerdenbag, H. J., Maurer, J. M. & Gareb, B., 7-Jan-2025, In: Pharmaceutics. 17, 1, 24 p., 74.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile13 Downloads (Pure) -
Optimization of the Production Process of Clinical-Grade Human Salivary Gland Organoid-Derived Cell Therapy for the Treatment of Radiation-Induced Xerostomia in Head and Neck Cancer
Zanten, J. V., Jorritsma-Smit, A., Westra, H., Baanstra, M., Bruin-Jellema, A. D., Allersma, D., Gareb, B. & Coppes, R. P., 21-Mar-2024, In: Pharmaceutics. 16, 3, 21 p., 435.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile6 Citations (Scopus)85 Downloads (Pure) -
Roadmap for the accelerated development and clinical translation of fluorescent tracers using adalimumab-680LT
van Dijken, R., Huizinga, H., Gareb, B., Dekkers, B., van Zanten, C., Nagengast, W. & Lub-de Hooge, M., 1-Jun-2024, In: Journal of Nuclear Medicine. 65, Supplement 2, 242048.Research output: Contribution to journal › Meeting Abstract › Academic
Open Access -
Development of a Personalized Tumor Neoantigen Based Vaccine Formulation (FRAME-001) for Use in a Phase II Trial for the Treatment of Advanced Non-Small Cell Lung Cancer
Oosting, L. T., Franke, K., Martin, M., Kloosterman, W. P., Jamieson, J. A., Glenn, L. A., de Jager, M. W., van Zanten, J., Allersma, D. P. & Gareb, B., Jul-2022, In: Pharmaceutics. 14, 7, 31 p., 1515.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile10 Citations (Scopus)492 Downloads (Pure) -
First-in-Human Phase I Clinical Trial of an SFV-Based RNA Replicon Cancer Vaccine against HPV-Induced Cancers
Komdeur, F. L., Singh, A., van de Wall, S., Meulenberg, J. J. M., Boerma, A., Hoogeboom, B. N., Paijens, S. T., Oyarce, C., de Bruyn, M., Schuuring, E., Regts, J., Marra, R., Werner, N., Sluis, J., van der Zee, A. G. J., Wilschut, J. C., Allersma, D. P., van Zanten, C. J., Kosterink, J. G. W. & Jorritsma-Smit, A. & 3 others, , 3-Feb-2021, In: Molecular Therapy. 29, 2, p. 611-625 15 p.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile63 Citations (Scopus)279 Downloads (Pure)
Press/Media
-
Nationaal Groeifonds investeert in UMCG-studies om ontwikkeling kankermedicijnen te versnellen
Gareb, B., Franke, L., Huls, G., van Meerten, T., Bremer, E., Kosterink, J. & van Zanten, C.
15/04/2022
1 item of Media coverage
Press/Media: Research › Professional